abstract |
The present invention relates to compounds according to the generalnformula (1) which bind to the NR3B1 receptor and act as antagonists ofnthe NR3B1 receptor. The invention further relates to the treatment ofndiseases and/or conditions through binding of said nuclear receptor bynsaid compounds and the production of medicaments using said compounds. |